APA (7th ed.) Citation

KE, U., FE, v. d. H., MJ, B., H, M., CL, M., CMAH, F., . . . SJ, v. K. (2025). Generation of patient-derived and gene-corrected hiPSC lines from Hereditary Hemorrhagic Telangiectasia type 2 patients with ACVRL1 c.1042delG mutation. Stem cell research, 88, 103812. https://doi.org/10.1016/j.scr.2025.103812

Chicago Style (17th ed.) Citation

KE, Urdaneta, van den Hil FE, Bouma MJ, Manjikian H, Mummery CL, Freund CMAH, Orlova VV, and van Kampen SJ. "Generation of Patient-derived and Gene-corrected HiPSC Lines from Hereditary Hemorrhagic Telangiectasia Type 2 Patients with ACVRL1 C.1042delG Mutation." Stem Cell Research 88 (2025): 103812. https://doi.org/10.1016/j.scr.2025.103812.

MLA (9th ed.) Citation

KE, Urdaneta, et al. "Generation of Patient-derived and Gene-corrected HiPSC Lines from Hereditary Hemorrhagic Telangiectasia Type 2 Patients with ACVRL1 C.1042delG Mutation." Stem Cell Research, vol. 88, 2025, p. 103812, https://doi.org/10.1016/j.scr.2025.103812.